US HHS publishes new report on personalised health care
This article was originally published in RAJ Devices
Executive Summary
A report by the US Department of Health and Human Services under its Initiative on Personalized Health Care examines the potential for new findings in genetics and other molecular-level medicine to improve the quality and cost-effectiveness of health care1,2. The report, entitled Personalized Healthcare: Pioneers, Partnerships, Progress, includes commissioned papers and community case studies that illustrate the early use of personalised healthcare techniques and examines the opportunities and challenges for different stakeholders in the healthcare sector.
You may also be interested in...
Stakeholders Deliberate on Developing US Social Media Guidance
Jeanette Marchant reports on discussions at the US Food and Drug Administration public hearing on how drug and medical device companies should use the internet and social media to promote regulated products.
Stakeholders Deliberate on Developing US Social Media Guidance
Jeanette Marchant reports on discussions at the US Food and Drug Administration public hearing on how drug and medical device companies should use the internet and social media to promote regulated products.
Asian group identifies criteria for device nomenclature system
The Asian Harmonization Working Party agreed six criteria for a medical device nomenclature system at its 14th meeting in Hong Kong on 4-7 November 20091. The requirements ? which will help in the selection of a nomenclature system service provider ? cover charges for using the system; its governance; ownership of the database; response times to requests; the system’s future development; and further use.